Viewing Study NCT04836156


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-31 @ 6:25 PM
Study NCT ID: NCT04836156
Status: RECRUITING
Last Update Posted: 2022-04-06
First Post: 2021-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module